Thursday, November 13th, 2008
The incidence rate of mesothelioma has steadily increased over the last several decades, but according to new research, cases of mesothelioma in the United States might be declining.
Pleural mesothelioma is a devastating disease almost exclusively caused by exposure to asbestos. It’s a rare form of cancer that has an extremely long latency period, typically lasting two and five decades. Due to this latency period, mesothelioma treatment options are usually limited to palliative treatment rather than curative.
The research was performed by a team at Health Sciences Practice in New York and appeared in the European Journal of Cancer Prevention. The study was carried out through the analysis of mesothelioma cancer rates in certain groups of people.
The research used data obtained from the National Cancer Institute’s Surveillance Epidemiology and End Results registry data from 1973 to 2002. In analyzing the data, the researchers analyzed patterns of mesothelioma incidence in males and females in five different age groups.
In addition, the researchers studied the rates for people who reached working age after asbestos exposure limits were set by the Occupational Safety and Health Administration.
The data indicated that while the incidence rate of mesothelioma is still higher than normal in the expected age groups, the overall incidence rate of mesothelioma is actually declining.
For people with little opportunity to suffer occupational exposure to asbestos, the rate is approximately one case in one million people – around 1.15 for males and 0.94 for females. The background rate is around one per million for both sexes under the age of 50.
The researchers also found that incidence rates were higher than the normal rate in certain locations, including locations on the West Coast where major shipyards are situated.
The mesothelioma incidence rate is declining for the older age groups, which contain people who were most likely to have experienced asbestos exposure in the past. However, the rate remains significantly higher for males aged 60 and older.

Related Topics ►



